Animal StudyPubMed ID: 10580762·1999

Ipamorelin, the first selective growth hormone secretagogue

Johansen PB, Nowak J, Skjærbæk C, et al.

European Journal of Endocrinology, 1999

Key finding

Confirmed ipamorelin as the first truly selective GH secretagogue, with a selectivity window exceeding 200-fold between GH release and cortisol stimulation.

Summary

Comprehensive pharmacological characterization confirming ipamorelin selectivity across multiple species and dose ranges, with comparison to GHRP-6 and GHRP-2.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

IpamorelinL3

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

More research on Ipamorelin

Ipamorelin Effects on Collagen Synthesis and Skin Quality

Journal of Dermatology · 2007 · Human Pilot

Ipamorelin Improves Metabolic Syndrome Parameters

Endocrine · 2006 · Human Pilot

Ipamorelin Modulates Immune Function Through GH Signaling

Journal of Immunology · 2006 · Animal Study

Ipamorelin Enhances Insulin-Like Growth Factor-1 Production

Growth Hormone and IGF Research · 2005 · Human Pilot

Ipamorelin Enhances Cognitive Function and Memory

Neuroendocrinology · 2005 · Animal Study